Salem Investment Counselors’s Astera Labs ALAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$86.4M Sell
178,908
-6,000
-3% -$1.59M 2.14% 13
2026
Q1
$20.3M Buy
184,908
+2,583
+1% +$368K 0.59% 33
2025
Q4
$30.3M Sell
182,325
-1,403
-0.8% -$235K 0.86% 23
2025
Q3
$36M Buy
183,728
+7,884
+4% +$1.3M 1.03% 19
2025
Q2
$15.9M Buy
+175,844
New +$13.9M 0.5% 41

Other funds holding ALAB

Salem Investment Counselors's ALAB Position: Q2 2026 in Review

Salem Investment Counselors reduced its Astera Labs (ALAB) stake by 3.2% in Q2 2026, selling an estimated $1.59M and leaving 178,908 shares worth $86.4M. The position accounts for 2.14% of the portfolio, ranked #13.

Salem Investment Counselors first reported a position in ALAB in Q2 2025 and has held it in 5 quarters since. 988 funds tracked by Wall St. Rank hold ALAB as of Q2 2026.

  • Salem Investment Counselors held 178,908 shares of Astera Labs worth $86.4M as of Q2 2026.
  • Salem Investment Counselors sold 6,000 Astera Labs shares in Q2 2026, an estimated $1.59M.
  • Astera Labs made up 2.14% of Salem Investment Counselors's portfolio in Q2 2026, its #13 holding.
  • Salem Investment Counselors first reported a position in Astera Labs in Q2 2025 and has held it in 5 quarters since.
  • 988 funds tracked by Wall St. Rank held Astera Labs as of Q2 2026.

Based on Salem Investment Counselors's 13F filing for Q2 2026, filed 14 Jul 2026.